Replies to post #1021 on VistaGen Therapeutics Inc (VTGN)

[Hedge Starz]

Lost Funding Expenses for these vacated projects is an Average of $100MIL per Company!! A $VSTA valuation is therefor astronomical as a Cost Cutter, but these salvaged drugs can also end up as success stories with Licensing rights - among others.

[Hedge Starz]

Once we near some LARGER Product Developments and Positive Results, WHAT Will it take for a RESEARCH REPORT to be done on $VSTA by a CREDIBLE Analyst?

No one here wants the typical mundane report by a paid pumper. We want REAL Scenarios for Each Division, Each Product, Valuations regarding COST Reduction Benefits if BigPharma uses $VSTA, as well as licensing capabilities for drugs we are targeting to save.

Any thoughts on getting analysts on board?